Cefixime Dosing in Elevated Creatinine
Yes, elevated creatinine requires dose adjustment for cefixime when creatinine clearance falls below 60 mL/min, but the drug can still be safely administered with appropriate modifications. 1
Dose Adjustment Algorithm
For patients with renal impairment, adjust cefixime dosing based on creatinine clearance (CrCl) as follows:
Adults with Renal Impairment 1
- CrCl ≥60 mL/min: No adjustment needed—use standard 400 mg daily dose 1
- CrCl 21-59 mL/min: Reduce to 260 mg daily (13 mL of 100 mg/5 mL suspension OR 6.5 mL of 200 mg/5 mL suspension) 1
- CrCl ≤20 mL/min: Reduce to 172 mg daily (8.6 mL of 100 mg/5 mL suspension OR 4.4 mL of 200 mg/5 mL suspension) 1
Dialysis Patients 1, 2
- Hemodialysis patients: Use the same dose as CrCl ≤20 mL/min (172 mg daily); supplemental dosing after dialysis is not necessary because hemodialysis removes an insignificant fraction of cefixime 1, 2
- Peritoneal dialysis patients: Use the same dose as CrCl ≤20 mL/min (172 mg daily); peritoneal dialysis removes only 1.57% of the drug over 72 hours 2
Pharmacokinetic Rationale
The need for dose adjustment stems from cefixime's renal elimination pathway:
- Approximately 40% of cefixime is cleared unchanged by the kidneys, with the remaining 60% undergoing hepatic metabolism 3
- In patients with CrCl <20 mL/min, the elimination half-life increases from 3-4 hours to 12-14 hours 4, 5
- Peak serum concentrations (Cmax) increase slightly in renal impairment, and drug accumulation occurs with repeated dosing if doses are not adjusted 4, 5
- Renal clearance declines proportionally with decreasing creatinine clearance 4
Critical Clinical Considerations
Extend the dosing interval rather than reducing individual doses to maintain adequate peak concentrations for bacterial killing while preventing accumulation 4. This approach is consistent with beta-lactam pharmacodynamics, where time above MIC is the key efficacy parameter 6.
Urinary concentrations remain therapeutic even in severe renal impairment:
- Cefixime concentrations in urine exceed MICs for most urinary tract pathogens for up to 24 hours post-dose, even with CrCl <20 mL/min 2
- This makes cefixime particularly suitable for treating urinary tract infections in patients with renal dysfunction 2
Common Pitfalls to Avoid
Do not use the Cockcroft-Gault equation alone for modern drug dosing decisions in renal impairment; validated GFR estimation equations incorporating serum creatinine (and potentially cystatin C) are now preferred 7, 8. However, the FDA label for cefixime references creatinine clearance, so clinical judgment is needed when translating eGFR values to dosing decisions 1.
Do not give supplemental doses after hemodialysis or peritoneal dialysis, as dialysis removes negligible amounts of cefixime from the body 1, 2. This differs from some other antibiotics where post-dialysis supplementation is required 9, 10.
Monitor for accumulation in severe renal impairment (CrCl <20 mL/min), where the half-life triples and steady-state concentrations increase significantly 4, 5. While cefixime is generally well-tolerated, prolonged exposure could theoretically increase adverse effect risk 4.